...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Message: "Later this quarter we'll announce some orphan indications that we'll be going..

I would suggest that some of the failings, (from an IR perspective) are perhaps by design. I'll post about it tonight.

New Message
Please login to post a reply